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Abstract
Calcium hydroxide, a widely used intracanal medicament, is known to exert an antimicrobial 
effect and degrade bacterial-derived lipopolysaccharides. However, little is known about the effect 
of Ca(OH)2 on endogenous inflammatory mediators such as interleukin-1α (IL-1α), tumor 
necrosis factorα (TNFα) and calcitonin gene-related peptide (CGRP). This is an important gap in 
knowledge since these inflammatory mediators play an important role in mediating the 
pathogenesis of periradicular periodontitis. We tested the hypothesis that Ca(OH)2 denatures 
IL-1α, TNFα and CGRP. Human IL-1α (0.125ng/ml), TNFα (0.2ng/ml) and CGRP (0.25ng/mL) 
were incubated with Ca(OH)2 (0.035mg/mL) for 1 to 7 days. At the end of the incubation period, 
the pH of the samples was neutralized and the concentrations of the mediators measured by 
immunoassays. Data were analyzed using one-way ANOVA and Bonferroni’s multiple 
comparison tests. The results indicate that Ca(OH)2 denatures IL-1α, TNFα and CGRP by 50–
100% over the testing periods (p<0.001). We conclude that denaturation of these pro-
inflammatory mediators is a potential mechanism by which Ca(OH)2 contributes to the resolution 
of periradicular periodontitis.
Introduction
Periradicular periodontitis is thought to represent an immunological and inflammatory 
response to microorganisms in infected root canal systems (1,2). In treating teeth with 
periradicular periodontitis, the goal of endodontic therapy is to eliminate or reduce 
intracanal microorganisms and promote healing of periradicular tissues. Antimicrobial 
intracanal medicaments such as calcium hydroxide are widely used in order to reduce the 
microbial load present in the root canal systems. In addition to its antimicrobial activity (3–
7), calcium hydroxide is also known for its ability to dissolve tissues (8–10), inhibit tooth 
resorption (11) and induce hard tissue formation (12). It reduces lipopolysaccharide (LPS)-
stimulated osteoclast formation (13) and attenuates the effect of LPS on expression of matrix 
metalloproteinase-1 (14).
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While most endodontic studies evaluating the role of calcium hydroxide as an intracanal 
medicament have focused on its effects on bacteria and their byproducts, the effects of 
calcium hydroxide on endogenous inflammatory mediators such as interleukin-1α (IL-1α), 
tumor necrosis factorα (TNFα) and calcitonin-gene related peptide (CGRP) are unknown. 
This is an important gap in knowledge since pro-inflammatory cytokines play an important 
role in regulating tissue inflammation, leading to the destruction of connective tissue 
matrices in inflammatory conditions such as periradicular periodontitis (15,16). These 
cytokines are also known to activate/sensitize nociceptors and contribute to the development 
of hyperalgesia (a stronger pain response to noxious stimuli) and allodynia (a decrease in 
pain threshold) (17–19).
Other mediators which are known to modulate tissue inflammation include neuropeptides 
such as CGRP. Inflamed pulpal and periradicular tissues contain higher levels of CGRP as 
compared to normal tissues (20). The release of CGRP into the peripheral tissues is known 
to cause vasodilation which results in increased plasma extravasation (21, 22) and to 
enhance the chemotactic activities of neutrophils (23, 24).
The antibacterial effect of calcium hydroxide is attributed to the release of its hydroxyl ions 
and several studies have demonstrated that after placement of calcium hydroxide in the root 
canal system, the hydroxyl ions diffuse through the dentinal tubules to the outer surface of 
the root (25–27). Based upon these reports, it is possible that calcium hydroxide exerts an 
immunomodulatory effect by local denaturation of inflammatory mediators, possibly via 
alkaline hydrolysis of amide bonds (28). This could potentially constitute a mechanism by 
which calcium hydroxide, when used as an intracanal medicament, contributes to the healing 
of inflamed periradicular tissues. Therefore, the present study tested that hypothesis that 
calcium hydroxide reduces levels of the inflammatory mediators IL-1α, TNFα and CGRP.
Materials and Methods
Human recombinant IL-1α and TNFα were purchased from R&D systems (Minneapolis, 
MN, USA) and were diluted using sterile phosphate buffered saline (PBS) with 1% bovine 
serum albumin to 0.125ng/mL and 0.2ng/ml respectively. Human CGRP was purchased 
from SPI-BIO (Montigny le Bretonneux, France) and was diluted to 0.25ng/ml. The 
concentrations of these inflammatory mediators are within the physiologic range found in 
pulpal and periradicular tissues as well as other orofacial tissues (31–33). IL-1α 
(0.125ng/mL) was incubated with calcium hydroxide (0.035%) (UltraCal XS™, Ultradent 
products Inc. South Jordan, UT, USA) for 1, 3 and 7 days at 37°C. TNFα (0.2ng/mL) was 
incubated with calcium hydroxide (0.035%) for 1 and 7 days at 37°C. CGRP (0.25ng/ml) 
was incubated with calcium hydroxide (0.035%) at 37°C or at 2°C for 1 and 3 days. At the 
end of the incubation period, the samples were centrifuged and the aspirates collected. The 
pH of the aspirates was neutralized using 0.1N HCl and the concentrations of IL-1α, TNFα 
and CGRP were measured using ELISA (R&D systems, Minneapolis, MN, USA and SPIBio 
Montigny le Bretonneux, France). Controls were samples prepared under identical 
conditions but which were incubated with PBS instead of calcium hydroxide. All samples 
were run in duplicates. Data were analyzed using one-way ANOVA and Bonferroni’s 
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multiple comparison tests. The significance level was set at 0.05. Data are presented as mean 
± SD.
Results
Incubation with calcium hydroxide resulted in a complete loss of detectable IL-1α at all time 
points examined (p<0.001) (Figure 1). A time-dependent decrease in levels of IL-1α was 
noted in the controls. Levels of IL-1α were lower in the 7 day controls as compared to the 1 
day controls (p<0.05).
Calcium hydroxide had a similar effect on TNFα. Incubation of TNFα with calcium 
hydroxide for 1 or 7 days resulted in 66–100% loss of TNFα (p<0.001) (Figure 2). Seven 
days of incubation with calcium hydroxide resulted in decrease in TNFα below the levels 
detectable by the ELISA. The levels of TNFα in the 7 day control sample were significantly 
lower than those in the 1 day control sample (p<0.001).
For the CGRP experiments, incubation at 37°C resulted in a significant and nearly complete 
denaturation of CGRP in the controls as well as the experimental samples (data not shown) 
and as such we were unable to draw any comparisons between the samples and the controls. 
We then repeated the experiment at 2°C. Incubation of CGRP with calcium hydroxide 
resulted in a decrease in levels of CGRP (p<0.001) (Figure 3). The level of CGRP in the 3 
day controls was lower than that in the 1 day control (p<0.001).
Discussion
The results of this study demonstrate that under the experimental conditions used, calcium 
hydroxide effectively denatures immunoreactive IL-1α, TNFα and CGRP. The time points 
at which the effects of calcium hydroxide were examined were based on previous studies 
which reported diffusion of hydroxyl ions through the dentinal tubules to the outer root 
surface as early as 1 hr after placement of calcium hydroxide in the root canal system and 
were sustained for over 7 days (28–30). Additionally, when used as an intracanal 
medicament during non-surgical root canal therapy, calcium hydroxide dressing is usually 
left in the root canal space for a minimum of 7 days.
The concentration of calcium hydroxide in most commercial preparations ranges from 35 to 
70% and the pH is approximately 12.5 (29). A number of studies have examined the 
diffusion of hydroxyl ions across the dentinal tubules following placement of calcium 
hydroxide in the root canal systems (25,33). A recent in vitro study examined the diffusion 
of different preparations of calcium hydroxide (including the preparation used in this study 
UltraCal) in a simulated periradicular environment (34). The increase in pH in the 
periradicular environment following placement of UltraCal was in the range of 11.1±0.83. 
However, this study did not take into consideration the known buffering capacity of dentin. 
As such we diluted our samples a 1000 fold (ie, final concentration of 0.035%) and found 
that, even at this dilution, calcium hydroxide retained a significant and substantial effect on 
the mediators examined.
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The diffusion of hydroxyl ions across dentinal tubules can be evaluated using different 
experimental methods. A commonly used method involves placing the samples in tubes/
vials of distilled water and then measuring changes in the pH of the water (34). Another 
approach is to place microelectrodes into cavities prepared on the root surface in order to 
measure changes in pH (25, 33). Both these methods are not truly reflective of the 
concentration of hydroxyl ions in the periradicular space in vivo as extracellular fluids 
contain buffers which maintain the pH within a range of 7.35 to 7.45. As such it is unlikely 
that the increase in pH which occurs following diffusion of hydroxyl ions into the 
periradicular space is sustained for long periods of time.
Clinical as well as preclinical studies have demonstrated increased expression of IL-1α and 
TNFα in periradicular periodontitis and in periapical granulomas (15, 16, 30, 35–39). In 
addition, levels of endogenous IL-1α and TNFα are positively correlated with pain reports 
in several clinical conditions (40–42). Administration of an IL-1 receptor antagonist or 
antibodies to TNFα in patients with chronic inflammatory conditions significantly reduced 
the pain experienced by these patients (43, 44). Under the experimental conditions used in 
this study, IL-1α and TNFα, both at physiologic levels, were effectively denatured by 
calcium hydroxide.
A characteristic feature of chronic apical periodontitis is extensive sprouting of peripheral 
peptidergic nerve fibers into the periradicular tissue. This extensive neuronal arborization 
occurs during the onset of periapical lesions with a selective increase in the neuropeptides 
CGRP and substance P (SP) (20, 45, 46). CGRP exerts a vasodilative effect on the 
microvascular system (22) which enhances plasma extravasation induced by other 
inflammatory mediators such as SP (21). The exudation of fluids and blood borne mediators 
such as kininogen and albumin results in the edema formation and in the liberation of 
bradykinin which is a highly potent stimulator of nociceptors. Thus it appears that CGRP 
contributes to both pain and inflammation.
In the present study, CGRP was incubated with calcium hydroxide at 2°C and not at body 
temperature as incubation at 37°C resulted in a significant denaturation of CGRP in the 
controls as well as the experimental samples. Under these conditions CGRP was effectively 
denatured by calcium hydroxide. It is likely that at higher temperatures calcium hydroxide 
denatures CGRP in an even more effective manner.
A limitation of this study is that it is conducted in vitro. The ideal way to evaluate the effect 
of calcium hydroxide on inflammatory mediators in the periradicular tissues would be to 
first collect exudates from teeth with periradicular periodontitis and then place calcium 
hydroxide as an intracanal medicament. Comparison of the initial periapical samples with 
those collected at subsequent appointments would be partially reflective of the therapeutic 
effect of calcium hydroxide on inflammatory mediators. However, it is also likely that the 
reduction in levels of inflammatory mediators at subsequent appointments would be partly 
due to a decrease in the microorganisms present in the root canal system. Thus this in vitro 
approach serves to evaluate the effect of calcium hydroxide on inflammatory mediators 
alone without any confounding additional effects.
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We do not advocate placing calcium hydroxide past the apex into the periradicular tissues. 
As calcium hydroxide is extremely alkaline it will cause severe tissue injury. Taken 
together, the data support the hypothesis that calcium hydroxide leads to substantial (50–
100%) and significant reduction in detectable levels of endogenous inflammatory mediators.
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Calcium hydroxide denatures IL-1α in vitro. Human IL-1α (0.125 ng/ml) was incubated 
with calcium hydroxide (0.035%) for 1, 3 and 7 days at 37°C. Controls were samples 
prepared under identical conditions but which were incubated with sterile phosphate 
buffered saline. Dashed line across the graph represents the minimal detectable 
concentrations of IL-1α in the ELISA kit used. Data were analyzed using one-way ANOVA 
and Bonferroni’s multiple comparison tests. ***p<0.001; *p<0.05
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Calcium hydroxide denaturesTNFα in vitro. Human TNFα (0.2 ng/ml) was incubated with 
calcium hydroxide (0.035%) for 1 and 7 days at 37°C. Controls were samples prepared 
under identical conditions but which were incubated with sterile phosphate buffered saline. 
Dashed line across the graph represents the minimal detectable concentrations of TNFα in 
the ELISA kit used. Data were analyzed using one-way ANOVA and Bonferroni’s multiple 
comparison tests. ***p<0.001
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Calcium hydroxide denatures CGRP in vitro. CGRP was incubated with calcium hydroxide 
(0.035%) for 1 and 3 days at 2°C. Controls were samples prepared under identical 
conditions but which were incubated with sterile phosphate buffered saline. Data were 
analyzed using one-way ANOVA and Bonferroni’s multiple comparison tests. ***p<0.001
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